• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ADVM

ADVM

Adverum Biotechnologies, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.36

+0.00 (+0.00%)

Company Profile

CEO

Laurent Fischer

IPO Date

2014-07-31

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.24

Prev. Close

$4.36

Day Low

$4.24

Day High

$4.36

52W Low

$1.78

52W High

$6.07

Market Cap

$0.10B

Volume

0.68M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

13.1%

Avg Negative

16.9%

Avg Neutral

69.9%

News Feed

Adverum Announces Changes to Management Team

GlobeNewsWire·6/24/2021·↑ positive

A Trio of Net Current Asset Value Stock Picks

GuruFocus·6/9/2021·↓ negative

Why Adverum Biotechnologies Stock Sank in May

The Motley Fool·6/7/2021·↓ negative

Are Options Traders Betting on a Big Move in Adverum (ADVM) Stock?

Zacks Investment Research·5/18/2021·↓ negative

Adverum Biotechnologies (ADVM) is Oversold: Can It Recover?

Zacks Investment Research·5/17/2021·↑ positive

The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting

Business Wire·5/12/2021·↑ positive

Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting

GlobeNewsWire·5/12/2021·↑ positive

The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders

Business Wire·5/11/2021·↓ negative

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM

PRNewsWire·5/11/2021·↓ negative

The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual Meeting

Business Wire·5/10/2021·↑ positive